Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Feasibility of establishing a biosafety level 3 tuberculosis culture laboratory of acceptable quality standards in a resource-limited setting: an experience from Uganda.

Autor: Ssengooba W, Gelderbloem SJ, Mboowa G, Wajja A, Namaganda C, Musoke P, Mayanja-Kizza H, Joloba ML; Department of Medical Microbiology, Makerere University College of Health Sciences, School of Biomedical Sciences, P,O, Box 7072, Kampala, Uganda. moses.joloba@case.edu.

Publikováno v: Health research policy and systems [Health Res Policy Syst] 2015 Jan 15; Vol. 13, pp. 4. Date of Electronic Publication: 2015 Jan 15.

Bacillus Calmette-Guérin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles.

Autor: Soares AP; South African TB/Institute of Infectious Diseases and Molecular Medicine and School of Child and Adolescent Health, Vaccine Initiative, University of Cape Town, Cape Town, South Africa., Scriba TJ, Joseph S, Harbacheuski R, Murray RA, Gelderbloem SJ, Hawkridge A, Hussey GD, Maecker H, Kaplan G, Hanekom WA

Publikováno v: Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2008 Mar 01; Vol. 180 (5), pp. 3569-77.

Dose-dependent immune response to Mycobacterium bovis BCG vaccination in neonates.

Autor: Davids V; South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Hanekom W, Gelderbloem SJ, Hawkridge A, Hussey G, Sheperd R, Workman L, Soler J, Murray RA, Ress SR, Kaplan G

Publikováno v: Clinical and vaccine immunology : CVI [Clin Vaccine Immunol] 2007 Feb; Vol. 14 (2), pp. 198-200. Date of Electronic Publication: 2006 Dec 20.